New H_1/H₃ antagonists for treating allergic rhinitis: WO2010094643

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 3, 2011-03 ,pp. : 425-429

Informa Healthcare

Access to resources Recommend Favorite

Treating Allergic Rhinitis in Pregnancy: Safety Considerations

By Mazzotta P.   Loebstein R.   Koren G.  

Drug Safety, Vol. 20, Iss. 4, 1999-04 ,pp. : 361-375

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis: Assessment during the Spring and Fall Allergy Seasons

By Meltzer E.O.  

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 25-32

Adis International

Access to resources Recommend Favorite

Loratidine buccal films for allergic rhinitis: development and evaluation

By Kumria Rachna   Nair Anroop B.   Al-Dhubiab Bandar E.  

Drug Development and Industrial Pharmacy, Vol. 40, Iss. 5, 2014-05 ,pp. : 625-631

Informa Healthcare

Access to resources Recommend Favorite

Correlations of Health-related Quality of Life Questionnaire Results in Asthma and Allergic Rhinitis: Effects of a Leukotriene Receptor Antagonist

By Ichimaru Y   Kanazawa H   Kamoi H   Kyoh S   Tochino Y   Kodama T   Hirata K  

The Journal of International Medical Research, Vol. 36, Iss. 3, 2008-05 ,pp. : 559-566

Field House Publishing

Access to resources Recommend Favorite